FDA Investigator

Jonathan R Campos

Latest inspection on record: Renton, United States, June 2025 · records back to 2012

Human DrugsMedical Devices & Rad HealthFoods & CosmeticsAnimal Drugs & FeedsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 200 inspections across 191 sites are on record.
  • 233 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-06-05.

At a glance

Inspections

200

Sites

191

Observations

233

Career since

Aug 2012

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Frances E Broyles, M.D.5 Jun 2025Medical Devices & Rad Health
Himanshukumar Amin, M.D.7 Mar 2025Human Drugs
Raju Lingumpelly, MBBS28 Feb 2025Human Drugs
Erik W. Anderson, MD19 Dec 2024Human Drugs
MPP PHARMA LLC20 Sep 2024Human DrugsView 483 →

Sites inspected

Frances E Broyles, M.D.Renton, United States1 insp.
Himanshukumar Amin, M.D.Vadodara, India1 insp.
Raju Lingumpelly, MBBSHyderabad, India1 insp.
Erik W. Anderson, MDColorado Springs, United States1 insp.
MPP PHARMA LLCKansas City, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Jonathan R Campos' 233 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site